Previous 10 | Next 10 |
Calyxt, Inc. (NASDAQ:CLXT), a healthy food ingredients company, will host an Investor & Analyst Day at the Company’s headquarters on Tuesday, June 25, 2019. During the event, the Company will reiterate its 2019 financial guidance and give a business update covering the following ...
Collaboration positions Calyxt’s high oleic soybean meal for sale into the dairy nutrition market Calyxt, Inc. (NASDAQ: CLXT), a healthy food ingredients company, today announced that it has entered into a commercial crushing agreement with Landus Cooperative, significantly e...
Noteworthy events during the week of June 23 - 29 for healthcare investors. More news on: Palatin Technologies, Inc., Calyxt, Inc., Acer Therapeutics Inc., Healthcare stocks news, , Read more ...
Agricultural biotechs Arcadia Biosciences ( RKDA +15.9% ) and Yield10 Bioscience ( YTEN +5.4% ) are both up on increased volume in apparent response to an executive order from President Trump to federal agencies to ease the rules for approving genetically modified crops and other agric...
Calyxt, Inc. (NASDAQ:CLXT), a healthy food ingredients company, will host an Investor & Analyst Day at the Company’s headquarters on Tuesday, June 25, 2019 from noon – 5 p.m. CDT. Attendees will have the opportunity to hear directly from Calyxt leadership on its plant...
The following slide deck was published by Calyxt, Inc. in conjunction with this Read more ...
Calyxt, Inc. (NASDAQ: CLXT), a healthy food ingredient company, announced today the appointment of Dr. Travis Frey as Chief Technology Officer, effective May 20, 2019. Dr. Frey brings his extensive knowledge in plant biology and biotechnology to a newly created position at the Company. As ...
Make no mistake, Calyxt ( CLXT ) still has a long row to hoe. Although this bio-ag has now logged its first commercial sales in multiple product types, the company is likely somewhere around five years away from its first profitable quarters and six or so years away from being free cash flow...
Calyxt, Inc. (CLXT) Q1 2019 Earnings Conference Call May 8, 2019 8:30 a.m. ET Company Participants Simon Harnest - VP, Finance Jim Blome - CEO Manoj Sahoo - Chief Commercial Officer Bill Koschak - CFO Conference Call Participants Adam Samuelson - Goldman Sachs Daniel Je...
Calyxt (NASDAQ: CLXT ): Q1 GAAP EPS of -$0.23 beats by $0.03 . More news on: Calyxt, Inc., Earnings news and commentary, Energy stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Shares of Calyxt, Inc. (NASDAQ: CLXT) traded at a new 52-week high today and are currently trading at $5.4. So far today, approximately 55,181 shares have been exchanged, as compared to an average 30-day volume of 89,248 shares. Calyxt, Inc., a synthetic biology company, engages in delivering...
Calyxt Announces Stockholder Approval of Merger With Cibus PR Newswire -- Calyxt Announces 1-for-5 Reverse Stock Split of Common Stock -- ROSEVILLE, Minn. , May 19, 2023 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT) ("Calyxt" or the "Company") today announc...
Calyxt Reports First Quarter 2023 Financial Results and Provides Corporate Update PR Newswire —P roposed merger with Cibus Global Expected to Close in Q2 2023 — —1-for-10 reverse stock split executed— —Current customer...